Monica Calderón-Goercke

621 total citations
19 papers, 234 citations indexed

About

Monica Calderón-Goercke is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Monica Calderón-Goercke has authored 19 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 14 papers in Rheumatology and 4 papers in Surgery. Recurrent topics in Monica Calderón-Goercke's work include Vasculitis and related conditions (11 papers), Otitis Media and Relapsing Polychondritis (9 papers) and Systemic Lupus Erythematosus Research (5 papers). Monica Calderón-Goercke is often cited by papers focused on Vasculitis and related conditions (11 papers), Otitis Media and Relapsing Polychondritis (9 papers) and Systemic Lupus Erythematosus Research (5 papers). Monica Calderón-Goercke collaborates with scholars based in Spain and South Africa. Monica Calderón-Goercke's co-authors include Miguel Á. González‐Gay, Santos Castañeda, D. Prieto-Peña, Ricardo Blanco, Ignacio Banzo, I. Martínez‐Rodríguez, José L. Hernández, Alfonso Corrales, Trinitario Pina and J. Loricera and has published in prestigious journals such as Annals of the Rheumatic Diseases, Biochemical Pharmacology and Seminars in Arthritis and Rheumatism.

In The Last Decade

Monica Calderón-Goercke

15 papers receiving 232 citations

Peers

Monica Calderón-Goercke
Ana Águeda Portugal
Monica Calderón-Goercke
Citations per year, relative to Monica Calderón-Goercke Monica Calderón-Goercke (= 1×) peers Ana Águeda

Countries citing papers authored by Monica Calderón-Goercke

Since Specialization
Citations

This map shows the geographic impact of Monica Calderón-Goercke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Calderón-Goercke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Calderón-Goercke more than expected).

Fields of papers citing papers by Monica Calderón-Goercke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Calderón-Goercke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Calderón-Goercke. The network helps show where Monica Calderón-Goercke may publish in the future.

Co-authorship network of co-authors of Monica Calderón-Goercke

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Calderón-Goercke. A scholar is included among the top collaborators of Monica Calderón-Goercke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Calderón-Goercke. Monica Calderón-Goercke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Calderón-Goercke, Monica, Santos Castañeda, Ignacio Villa, et al.. (2021). Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients. Seminars in Arthritis and Rheumatism. 51(2). 387–394. 17 indexed citations
2.
Martínez‐Rodríguez, I., Belén Atienza‐Mateo, Monica Calderón-Goercke, et al.. (2021). Evidence for uncoupling of clinical and 18-FDG activity of PET/CT scan improvement in tocilizumab-treated patients with large-vessel giant cell arteritis. Clinical and Experimental Rheumatology. 39(2). 69–75. 37 indexed citations
3.
Prieto-Peña, D., Monica Calderón-Goercke, Víctor Manuel Mora Cuesta, et al.. (2020). Long-term survival of lung transplantation for interstitial lung disease associated with connective tissue diseases: a study of 26 cases from a referral centre.. PubMed. 38(4). 615–620. 9 indexed citations
4.
Atienza‐Mateo, Belén, Sara Remuzgo‐Martínez, Víctor Manuel Mora Cuesta, et al.. (2020). The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation †. Journal of Clinical Medicine. 9(6). 1606–1606. 21 indexed citations
5.
Calderón-Goercke, Monica, J. Gonzalo Ocejo‐Vinyals, Juan Irure‐Ventura, et al.. (2020). AB0004 TLR10 SINGLE NUCLEOTIDE POLYMORPHISMS ARE ASSOCIATED WITH HIDRADENITIS SUPPURATIVA IN A CAUCASIAN SPANISH POPULATION (NORTHERN SPAIN). Annals of the Rheumatic Diseases. 79. 1306–1306. 2 indexed citations
6.
Prieto-Peña, D., Monica Calderón-Goercke, I. Martínez‐Rodríguez, et al.. (2020). SAT0568 PERSISTENT VASCULAR 18F-FDG UPTAKE DESPITE CLINICAL-ANALYTICAL REMISSION IN PATIENTS WITH LARGE VESSEL VASCULITIS UNDER TOCILIZUMAB THERAPY. SINGLE UNIVERSITARY CENTER EXPERIENCE OF 30 PATIENTS.. Annals of the Rheumatic Diseases. 79. 1242–1242. 2 indexed citations
7.
Prieto-Peña, D., Monica Calderón-Goercke, I. Martínez‐Rodríguez, et al.. (2020). FRI0215 RESPONSE TO TOCILIZUMAB IN LARGE VESSEL VASCULITIS ACCORDING TO THE EXTENT OF BASELINE 18F-FDG VASCULAR UPTAKE. Annals of the Rheumatic Diseases. 79. 691–691.
8.
González‐Gay, Miguel Á., D. Prieto-Peña, I. Martínez‐Rodríguez, et al.. (2019). Early large vessel systemic vasculitis in adults. Best Practice & Research Clinical Rheumatology. 33(4). 101424–101424. 28 indexed citations
9.
Prieto-Peña, D., J. L. Martín-Varillas, Monica Calderón-Goercke, et al.. (2019). SAT0512 LONG-TERM FOLLOW-UP OF CARDIOVASCULAR OUTCOMES IN KAWASAKI DISEASE. OBSERVATIONAL STUDY FROM A SINGLE CENTER. Annals of the Rheumatic Diseases. 78. 1345–1346. 1 indexed citations
10.
Martín-Varillas, J. L., Belén Atienza‐Mateo, J. Loricera, et al.. (2019). FRI0202 SHORT AND LONG-TERM FOLLOW-UP OF APREMILAST THERAPY IN REFRACTORY SKIN LUPUS LESIONS. Annals of the Rheumatic Diseases. 78. 780–780.
11.
Prieto-Peña, D., Monica Calderón-Goercke, Víctor Manuel Mora Cuesta, et al.. (2019). OP0169 LONG-TERM SURVIVAL IN LUNG TRANSPLANTATION FOR INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONECTIVE TISSUE DISEASES. STUDY OF 26 CASES OF A SINGLE CENTER. Annals of the Rheumatic Diseases. 78. 160–161. 1 indexed citations
12.
Martín-Varillas, J. L., Belén Atienza‐Mateo, D. Prieto-Peña, et al.. (2019). FRI0612 IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH IMMUNOTHERAPY. LONG-TERM FOLLOW-UP OF 102 PATIENTS FROM A REFERRAL SINGLE CENTER. Annals of the Rheumatic Diseases. 78. 1002–1002.
13.
Prieto-Peña, D., Monica Calderón-Goercke, V. Calvo-Río, et al.. (2019). THU0581 BIOLOGICAL THERAPY IN NON ISCHAEMIC OPTIC NEURITIS ASSOCIATED TO IMMUNE-MEDIATED INFLAMMATORY DISEASES. MULTICENTER STUDY. Annals of the Rheumatic Diseases. 78. 581–582.
14.
González‐Gay, Miguel Á., Trinitario Pina, D. Prieto-Peña, et al.. (2019). Treatment of giant cell arteritis. Biochemical Pharmacology. 165. 230–239. 13 indexed citations
16.
Prieto-Peña, D., I. Martínez‐Rodríguez, J. Loricera, et al.. (2018). Predictors of positive 18F-FDG PET/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica. Seminars in Arthritis and Rheumatism. 48(4). 720–727. 75 indexed citations
17.
González‐Gay, Miguel Á., Trinitario Pina, D. Prieto-Peña, et al.. (2018). The role of biologics in the treatment of giant cell arteritis. Expert Opinion on Biological Therapy. 19(1). 65–72. 6 indexed citations
18.
González‐Gay, Miguel Á., Trinitario Pina, D. Prieto-Peña, et al.. (2018). Current and emerging diagnosis tools and therapeutics for giant cell arteritis. Expert Review of Clinical Immunology. 14(7). 593–605. 16 indexed citations
19.
González‐Gay, Miguel Á., Trinitario Pina, D. Prieto-Peña, et al.. (2018). Drug therapies for polymyalgia rheumatica: a pharmacotherapeutic update. Expert Opinion on Pharmacotherapy. 19(11). 1235–1244. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026